Aclaris Therapeutics Inc. logo

Aclaris Therapeutics Inc. (ACRS)

Market Closed
4 Apr, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1. 40
-0.09
-6.04%
$
215.72M Market Cap
- P/E Ratio
0% Div Yield
812,300 Volume
-1.64 Eps
$ 1.49
Previous Close
Day Range
1.34 1.46
Year Range
0.95 5.17
Earnings results expected in 60 days
Want to track ACRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
6 Jun 2025 (60 Days)
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
25 Feb 2025
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
4 Nov 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
7 Aug 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
5 Aug 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
6 Jun 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
27 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
23 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
21 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
6 Nov 2023
-
Cons. EPS
-
EPS